Investigating Patient Satisfaction With Oral Anti-Cancer Treatment (IPSOC)

Catholic University (KU) of Leuven

Status: Completed

Conditions: Clear Cell Renal Cell Carcinoma

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02247583

s52586 (Registry Identifier)

VF/2010/03

Details and patient eligibility

About

Prospective non-interventional non-controlled multicenter observational study to evaluate aspects of pharmaceutical care in patients with advanced renal cell carcinoma treated with an oral anti-cancer drug.

The main objective of this study is to evaluate the patient perspective in the treatment of advanced renal cell carcinoma with an oral anti-cancer drug.

The following aspects will be investigated:

• Intrinsic desire for information about treatment.
• Patient satisfaction with treatment information.
• Patient satisfaction with treatment.
• Medication adherence.
• Health-related quality of life.
• The role of different health care professionals in the treatment of RCC with oral drugs

This study should reveal information necessary for the development of pharmacotherapeutic care concepts that meet the needs of cancer patients treated with an oral anti-cancer drug over a long period.

Enrollment: 90 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are 18 years or older, and who can be contacted by phone and/or e-mail are eligible for the study

Exclusion criteria

• Patients who are not able to understand Dutch or French will be excluded from the study

Trial design

90 participants in 1 patient group

mRCC patients

Description:

Patients with metastatic renal cell carcinoma